A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ injury and inflammation, the discovery could pave the way for more effective treatments for the millions affected by TMJ-related facial pain.

No one looks forward to a colonoscopy. The procedure, which is used to screen for colorectal cancers, is unpleasant and costly and can lead to medical complications. But screening for the cancer is critical; colon cancer is the second leading cause of cancer-related death in the U.S., according to the National Cancer Institute.

A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of intracranial pressure (ICP) more accurately than existing non-invasive methods. This is the result of a study published in the journal npj Digital Medicine by researchers from the University of São Paulo in Brazil, the University of Cambridge in the United Kingdom, Emory University in the United States, and the company itself.

Surgical adhesions—common, sometimes life-threatening complications that arise after open or laparoscopic abdominal surgery—can be prevented in mice and pigs by a gel impregnated with a molecule that blocks a key signaling pathway in the formation of scar tissue.

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells’ ability to repair the lungs, helping explain the lingering effects of long COVID. The findings suggest a new treatment approach for long COVID as well as other conditions, both short-term and chronic, caused by respiratory infections such as the flu.

HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ — Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS).

SAN JOSE, Calif., March 13, 2025 /PRNewswire/ — Vave Health proudly announces the launch of its Universal Wireless Probe. This simple, innovative device is designed to enhance efficiency, accuracy, and diagnostics in a variety of clinical and educational settings. Its combination of linear and phased imaging technology provides high quality, full-body imaging with no ongoing subscription fees or hidden costs.

Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 clinical trial.